NAME: Michael Stuart Bronze, MD., MACP, FIDSA

1

CURRICULUM VITAE

NAME: Michael Stuart Bronze, MD., MACP, FIDSA

OFFICE ADDRESS:

Department of Medicine

PO Box 26901, WP1140

Oklahoma City, OK 73126-0901

EDUCATION:

High School: East High School, Memphis, TN June, 1972

Undergraduate:

University of Memphis, Sept., 1972- June 1975, BA with distinction (Political Science), July 1975.

University of Memphis, July, 1975- July 1978,

BS with distinction (Physical Science) August 1978.

Graduate/Professional School:

University of Tennessee, Memphis, August 1978 - June 1982, MD.

INTERNSHIP:

Medicine Internship, University of Tennessee, Memphis, July 1, 1982-June 30, 1983

RESIDENCY:

Internal Medicine, University of Tennessee, Memphis, July 1, 1983-June 30, 1985.

Chief Medical Resident, VAMC/UT Memphis, July 1, 1985- June 30, 1986.

POSTGRADUATE:

Fellow, Division of Infectious Diseases, Department of Medicine, University of Tennessee, Memphis July 1, 1986-June 30, 1988.

HONORS:

Phi Kappa Phi, University of Memphis Chapter, 1975

Valedictorian, University of Memphis, 1975.

Alpha Omega Alpha, University of Tennessee College of

Medicine, 1981

Recipient of training funds under NIH Grant No. USPHS AI- 07238,

1986-87

Recipient of Golden Apple Teaching Award, UT, 1992

Recipient Distinguished Service Award, Southern

Section, American Federation for Medical Research, 1997

Recipient of Outstanding Clinical Instructor Award, UT

1998

Recipient "Top Twenty Teachers" Award from House Staff,

1999.

Fellow, Infectious Diseases Society of American, 1999.

Recipient, “Top Twenty Teachers” Award from House Staff, UT, 2000.

Recipient, “Outstanding Faculty Award”, Department of Medicine, OUHSC, 2001-2002.

Kerr-McGee Presidential Professorship, July 2004-June 2008, University of Oklahoma Health Sciences Center.

Charlotte S. Leebron Memorial Trust Fund Award, April 2005 presented by the Oklahoma State Medical Association.

Fellow, American College of Physicians, 2005.

Charlotte S. Leebron Memorial Trust Fund Award, April 2007, presented by the Oklahoma State Medical Association.

Selected for the Best Doctors in America recognition (multiple years).

America’s Top Physicians, Consumers Research Council of America, 2009

Oklahoma’s Top Doctors, 2009, 2011.

Recipient, Founder’s Medal, Southern Society for Clinical Investigation, February, 2011.

David Ross Boyd Professor of Medicine, OUHSC, 2011- present

Internal Medicine Award for Superior Teaching, Department of Medicine, OUHSC, Fall 2011.

Inaugural Member, Academy of Teaching Scholars, OUHSC, 2012-present.

Recipient, “Outstanding Teaching Faculty Award”, Department of Medicine, OUHSC, AY12-13.

Tenth Ebert Visiting Professor, University of Arkansas School of Medicine, November 2013

OU Medicine Award for Outstanding Patient Service, 2013.

Master, American College of Physicians, 2014

MILITARY SERVICE:None

BOARD CERTIFICATION:

National Board of Medical Examiners, 1983.

American Board of Internal Medicine, 1985

American Board of Internal Medicine's Subspecialty Exam in Infectious Diseases, November 1, 1988.

LICENSURE:

Tennessee, MDO14828, July 1983-2000.

Oklahoma, 21683, July 2000

SOCIETY MEMBERSHIPS:

American Federation for Clinical Research, member

Lancefield Society, member

Memphis Infectious Disease Society

Memphis Academy of Internal Medicine

Association of Program Directors in Internal Medicine

American Society for Microbiology, member

Infectious Diseases Society of America, member

Infectious Diseases Society of Tennessee, member

Southern Society for Clinical Investigation (SSCI), member

American Society of Internal Medicine, member

Tennessee Society of Internal Medicine, member

American College of Physicians, member

American College of Physician Executives, member

Oklahoma County Medical Society, member

Oklahoma Chapter, ACP-ASIM, member

Oklahoma State Medical Association, member

American Medical Association, member

Association of Professors of Medicine

Association of Chiefs of General Internal Medicine

Alliance for Academic Internal Medicine

Association for American Medical Colleges (AAMC)

UNIVERSITY APPOINTMENTS:

Instructor, Division of Infectious Diseases, University of Tennessee, Memphis, October 1987.

Assistant Professor of Medicine, University of Tennessee, Memphis, July, 1988 - 1993.

Associate Professor of Medicine, University of Tennessee, Memphis, July 1993-1999.

Associate Professor of Medicine, University of Tennessee, Memphis with the award of tenure, 1994-1999.

Professor of Medicine, University of Tennessee, Memphis, 1999-2000.

Professor of Medicine with tenure, University of Oklahoma Health

Science Center, Oklahoma City, 2000-present.

Chairman, Department of Medicine, OUHSC, 2000-present

Stewart G. Wolf Endowed Chair in Internal Medicine, OUHSC, 2004- present.

David Ross Boyd Professor of Medicine, OUHSC, 2011- present

OTHER APPOINTMENTS:

Interim Chief Medical Officer, OU Medical Center, July 1, 2007-June 30, 2009.

Board of Directors, Academic Physicians Insurance Corporation, April 2006- present.

1. Chair, Underwriting Committee, 2006-2009
2. Member, Claims Committee, 2009-present
3. Chairman, APIC Board of Directors, April 1, 2009-present

Chief, Medicine Service, OU Medical Center, 2000-present.

Member, Regional Centers of Excellence Regional Advisory Committee (UTMB, Galveston], December, 2002- present.

Member, Advisory Board, Southwest Center for Public Health Preparedness, University of Oklahoma, October 2002-present

Member, Board of Visitors, Department of Internal Medicine, OUHSC, 2011-present.

Member, Board of Trustees, OU Medical Center, May 2011- present.

Chair, Board of Directors, Alliance for Academic Internal Medicine, 2013-2015

Member of Board of Governors, American College of Physicians, 2015-2019.

Member, Executive Committee, BOG, American College of Physicians- 2015-2016

Other appointments at UTHSC

Associate Chief Medical Officer, UT Medical Group, 1999 - 2000.

Associate Chairman, Clinical Operations, Department of Medicine, April 1997 to 2000.

Board of Directors, UT Medical Group, July 1997 to 2000.

Executive Committee, UT Medical Group, February 1999 to present.

Member at Large, Medical Executive Committee UT Bowld Hospital

1996 – 2000.

Associate Chairman Graduate Medical Education, Department ofMedicine, July 1993 to June 1997.

Assistant Program Director and then Program Director, Internal Medicine Residency, July, 1988-June 1997.

Associate Chief, Medical Service, VAMC, Memphis, July, 1988-1994

Co-Director, Infectious Diseases Fellowship Program, July 1, 1991to 2000.

Associate Director, Internal Medicine Residency and Medicine- Pediatrics Programs, October, 1987- June 1992.

Assistant Chairman, Department of Medicine, April, 1991- 1993.

Consultant Physician, Mid-South Foundation for Medical Care,July, 1989- 2000.

Consultant, Arlington Developmental Center (Physician Consultation Services, Quality Assurance), 1993-2000.

Chairman, Professional Advisory Board, Kimberly Quality Care, Inc. 1989-1995.

HOSPITAL APPOINTMENTS:

1. University Hospital, Oklahoma City, OK, Active Staff, 2000- present.

1. VA Hospital Oklahoma City, Active Staff, 2000-present.
2. OU Medical Center Hospital, Active Staff, 2000-present.
3. UT Bowld Hospital, Memphis, TN, Active Staff, 1987-2000.
4. VA Medical Center, Memphis, TN, Active Staff, 1987-2000.
5. Regional Medical Center, Memphis, Active Staff, Infectious Diseases and general Internal Medicine, 1987- 2000.
6. Baptist Memorial Hospital, Memphis, Active Staff, Infectious Diseases and general Internal Medicine, 1987- 2000.

TEACHING EXPERIENCE:

Medical Student, University of Tennessee:

Second Year Courses:

1. Pathology CPC- 2 hours, entire class
2. Pathophysiology- 1 hour, entire class

Third Year Internal Medicine Clerkship: University of Tennessee

1. Attend on general medicine wards 2-3 mos. per academic year. Contact occurs with 4-5 students at approximately 14-20 hours per week.
2. Conduct Professor's Conference with junior clerks on alternate weeks.

Fourth Year Infectious Diseases Elective/Junior Internship University of Tennessee

1.Serve as attending physician on the ID consult service through which students may elect a rotation. Contact time is approximately 10 hours per week.

2.Serve as attending physician for junior internship in internal medicine 2 months per year. Contact is with 2-3 students at 15 hours per week.

3.Serve as attending physician in general internal medicine clinic for senior students during their ambulatory clerkship.

Residency, Internal Medicine: University of Tennessee

1. Coordinated the recruitment, education and evaluation of the Department’s Internal Medicine Residency. The residency consisted of 125 trainees and 45 fellows.
2. Conduct Medicine Morning Report twice weekly.
3. Supervise Resident’s Continuity of Care Clinic, once on alternative weeks.
4. Faculty resident advisor.

Medical Student, University of Oklahoma:

Served as attending physician on General Medicine and ID Consult Services for 2 to 3 months per year. Conducted Professor’s conference on alternate weeks for M3 students.

Residency and Fellowship, University of Oklahoma:

Coordinated the Department of Medicine’s graduate education training programs consisting of 120-130 residents and fellows. Involved in the generation of curriculum, competency standards and accreditation of the programs.

EDITORIAL APPOINTMENTS/REVIEWER:

Editorial Boards:

Editorial Committee, American Journal of Medical Sciences

Chief Editor, Infectious Diseases section, Consumer Health Site, eMedicine.com

Chief Editor, Infectious Diseases Section, eMedicine.com- 2006-present

Editorial Board, eMedicine.com

Editorial Board, BioMed Central Journals, 2005-present

Editorial Board, American Journal of Medicine, 2005- present

Editorial Consultant, Physician’s Information and Education Resource (PIER), American College of Physicians, 2005- 2009

Editorial Board, Journal of the Oklahoma State Medical Association, 2008-present.

Reviewer:

Reviewer, Infection and Immunity

Reviewer, Clinical Infectious Diseases

Reviewer, Medical and Pediatric Oncology

Reviewer, Canadian Journal of Infectious Diseases

Reviewer, Southern Medical Journal

Reviewer, Journal of the American Geriatrics Society

Reviewer, American Journal of Medical Sciences

Reviewer, Consultations in Primary Care: Consultant

Reviewer, Mayo Clinic Proceedings

Reviewer, Biological Research for Nursing

Reviewer, Microbes and Infection

Reviewer, Medical Science Monitor

Reviewer, Expert Opinion on Biological Therapy

Reviewer, American Journal of Medicine

Reviewer, Expert Opinion on Drug Development

PUBLICATIONS (JOURNALS):

1.Bronze MS, Dale JB, Seyer JM, Beachey EH. Protective and Heart Cross reactive Epitopes of Type 19 Streptococcal M Protein. Transactions of the Association of American Physicians. Volume C: 80-84, 1987.

2.Bronze MS, Beachey EH, Dale JB. Protective and Heart Cross-Reactive Epitopes Located Within the Amino-terminus of Type 19 Streptococcal M Protein. Journal of Experimental Medicine. 167: 1849, 1988.

3.Beachey EH, Bronze M, Dale JB, Kraus W, Poirier T, Sargent SJ. Protective and Autoimmune Epitopes of Streptococcal M Protein. Vaccine 6: 192-196, 1988.

4.Bronze MS, McKinsey DS, Beachey EH, Dale JB. Immunity Evoked by Locally Administered Group A Streptococcal Vaccines. Journal of Immunology. 141: 2767, 1988.

5.Bronze MS, McKinsey DS, Beachey EH and Dale JB. Pathogenesis of Group A Streptococci in Mice and Efficacy of Locally Administered Streptococcal Vaccines. Transactions of the Association of American Physicians, Volume CI: 88-92, 1988.

6.McDonell AH, Baird RW, Bronze MS. Intramedullary Tuberculomas of the Spinal Cord: A Case Report and Review. Reviews of Infectious Diseases, 12:432, 1990.

7. Baird RW, Bronze MS, Kraus W, Hill HR, Veasey G and Dale JB. Epitopes of Group A Streptococcal M Protein Shared with Antigens of Articular Cartilage and Synovium. Journal of Immunology, 146: 3132-3137, 1991.

8. Bronze MS, Courtney HS, and Dale JB. Localization of Cross-Protective Epitopes of the C-Terminus of Group A Streptococcal M Protein. Journal of Immunology, 148:888-893, 1992.

9. Courtney HS, von Hunolstein C, Dale JB, Bronze MS, Hasty DL and Beachey EH. Lipoteichoic Acid and M Protein: Dual Adhesins of Group A Streptococci. Microbial Pathogenesis. 12: 199-208, 1992.

10.Bronze MS, Baird RW, Courtney HS, and Dale JB. Passive Protection Against Group A Streptococcal Infection in Mice by Lipoteichoic Acid. Streptococci and Streptococcal Infections XIth Lancefield Symposium. 22: 129-132, 1992.

11.Dale, JB, Baird, RW, Bronze, MS, and Beachey, EH Tissue-cross reactive Epitopes of Streptococcal M Proteins. Streptococci and Streptococcal Infections, XI the Lancefield Symposium. 22: 168-170, 1992.

12.Bronze MS and Dale JB. Epitopes of Streptococcal M Protein that Evoke Antibodies that Crossreact with Human Brain. J. of Immunology. 151: 2820-2828, 1993.

13.Dale, JB, Baird, RW, Courtney, HS, Hasty, DH, and Bronze, MS Passive Protection of Mice Against Group A Streptococcal Pharyngeal Infection by Lipoteichoic Acid. Journal of Infectious Diseases. 169:319-323, 1994.

14.Wessels, MR and Bronze MS. Role of Hyaluronic Acid Capsule in Pharyngeal Colonization and Invasive Infection by Group A Streptococci. Pathogenic Streptococci: Present and Future. XII Lancefield Symposium, 455-457, 1994.

15.Lederer JW, Wessels MR, Bronze, MS, and Dale JB. Relative Contributions of Hyaluronate Capsule and M Protein to Resistance to Phagocytosis of Types 18 and 24 Group A Streptococci. Pathogenic Streptococci: Present and Future. XII Lancefield Symposium, 222-224, 1994.

16.Wessels MR and Bronze MS. Critical Role of the Group A Streptococcal Capsule in Pharyngeal Colonization and Infection in Mice. Proceedings National Academy of Sciences USA 91:12238-12242, 1994.

17.Courtney HS, Bronze MS, Dale JB, and Hasty DL. Analysis of the Role of M Protein in Group A Streptococcal Adhesion and Colonization by Omega-Interposon Mutagenesis. Infection and Immunity, 62: 4868-4873, 1994.

18.Bronze MS. Rheumatic Fever. In Conn's Current Therapy. Ed. Rakel, R.

WEB. Saunders, Philadelphia: 117-119, 1995.

19.Bronze, MS. Management of Infective Endocarditis. Saunders Manual of Medical Practice, ed. Rakel, R., 265- 268, 1996.

20.Bronze, MS and Dale JB. Re-emergence of Group A Streptococcal Infections and Acute Rheumatic Fever. American Journal of Medical Sciences; 311:41-54, 1996.

21.Whitby S, Schaberg DR, and Bronze, MS. Infective Endocarditis Due to S. pneumoniae Exhibiting High-Level Penicillin Resistance. Clinical Infectious Diseases. 23:1176, 1996.

22.Whitby S, Madu E. and Bronze, MS. Candida zeylanoides Infective Endocarditis Complicating Infection with Human Immunodeficiency Virus. The American Journal of Medical Sciences: 312:138-139, 1996.

23.Almeida RA, Luther DA, Kumar SJ, Calvinho LF, Bronze MS, and Oliver SP. Adherence of Encapsulated and Nonencapsulated Strains of Streptococcus Uberis to Bovine Mammary Epithelial Cells and Extracellular Matrix Proteins. J Vet Med B: 43:385-392, 1996.

24.Almeida RA, Luther DA, Kumar SJ, Calvinho LF, Bronze MS, and Oliver SP. Adherence of Streptococcus Uberis to Bovine Mammary Epithelial Cells and to Extracellular Matrix Proteins. Zentralbl Veterinarmed [B]: 43:385, 1996.

25.Bronze MS, Whitby S and Schaberg DR. Group G Streptococcal Arthritis: A Case Report and Review of the Literature. American Journal of the Medical Sciences: 313:239 -243, 1997.

26.Calvinho LF, Luther DA, Almeida RA, Bronze MS, Drabik JJ and Oliver SP. Detection of M-like protein and lipoteichoic acid in Streptococcus dysgalactiae isolated from bovine intramammary infections. Proceedings National Mastitis Council, 270-271, 1997.

27.Meacham RR, Headley AS, Bronze MS, Lewis JB, and Rester MM. Impending Paradoxical Embolism. Archives of Internal Medicine, 158: 438 - 448, 1998.

28.Chuang AW, Lewis JL, Golden E, and Bronze, MS. Citrobacter freundii Empyema in a Patient with Occult Pulmonary Histoplasmosis. The American Journal of Medical Sciences; 315:314-316, 1998.

29.Bronze MS, Warr G, Spigel D, and Smalley D. False Positive HIV ELISA Due to Acute Cytomegalovirus Infection. Clinical Infectious Diseases; 27:221-222, 1998.

30.Monkemuller KE and Bronze, MS. Immunoblastic Lymphadenopathy Presenting as an Acute Abdomen and Mixed Bacteremia with Eikenella corrodens and Group C Streptococci. Am J Gastroenterol; 93:652-653;1998

31.Shirwany A, Sargent SJ, and Bronze MS. Urinary Tract Aspergillus Infection in a Renal Transplant Patient. Clinical Infectious Diseases, 27:1336, 1998.

32. Bronze, MS. Clinical Competencies for HIV Care by the General Internist. Federation Council on Internal Medicine Task Force on Clinical Competencies, Graduate Education In Internal Medicine: A Resource Guide to Curriculum Development. volume 1, 101-108, 1997.

33.Self TH, Chrisman CR, Baciewicz AM, and Bronze MS. Isoniazid Drug and Food Interactions. The American Journal of Medical Sciences, 317:304-311, 1999.

34.Kanangat S, Meduri GU, Tolley EA, Patterson DR, Griffin JP, Meduri CU, Pak C, Bronze, MS and Schaberg DR. Effects of Cytokines and Endotoxin on the Intracellular Survival and Replication of Bacteria. Infection and Immunity, 67:2834-2840, 1999.

35.Bronze MS. Management of Infectious Endocarditis. Saunders Manual of Medical Practice, second edition, ed. Rakel R, 355-359, 2000.

36.Self TH, Chrisman CR, Baciewicz AM and Bronze, MD. Isoniazid Drug and Food Interactions: How to Manage or Avoid. Journal of Critical Illness, 14:396-397, 1999.40.

37.Bronze MS, Shirwany A, Corbett CE, and Schaberg DR. Pneumococcal Aortitis: Case Report and Review of the Literature. The American Journal of Medicine 107:627-630, 1999.

38.McLellan D, Phillips K, Corbett CE and Bronze MS. Sternal Osteomyelitis Caused by Mycobacterium tuberculosis: Case Report and Review of the Literature. American Journal of Medical Sciences, 319:250-254, 2000.

39.Monier P, McKown K, Bronze MS. Osteonecrosis of Bone Complicating Highly Active Antiretroviral Therapy in HIV Infection. Clinical Infectious Diseases, 31:1488-1492, 2000.

40.Kanangat S, Bronze MS, Meduri U, Postlethwaite A and Schaberg DR. Enhanced Extracellular Growth of Staphylococcus aureus in the Presence of Selected Peptide Fragments of Human IL-1ß. Journal of Infectious Diseases, 183:65-69, 2001.

42.Meduri GU, Kanangat S, Bronze M, Patterson DR, Meduri CU, Pak C, Tolley EA, Schaberg DR. Effects of methylprednisolone on intracellular bacterial growth.. Clin Diagn Lab Immunol. 8 (6):1156-63, 2001.

43.Clinical Competencies in HIV Management by General Internists, update. Federation Council of Internal Medicine Task Force on Clinical Competencies, in press.

44.Monier P and Bronze MS. Osteonecrosis of Bone Complicating HIV Infection. Clinical Infectious Diseases, 33:269-270, 2001.

45.Gonzalez G and Bronze MS. Proteus Infections. eMedicine Textbook. October 2001.

46.Meduri GU, Kanangat S, Bronze M, Patterson DR, Meduri CU, Pak Chol, Tolley EA, Schaberg DR. Effects of Methylprednisolone on Intracellular Bacterial Growth. Clinical and Diagnostic Laboratory Immunology, 8:1156-1163, 2001.

47.Bronze MS, Huycke M, Machado L, Voskuhl G, Greenfield R. Viral Agents as Biological Weapons and Agents of Bioterrorism, American Journal of Medical Sciences, 323:316-325, 2002.

48.Evans RG, Crutcher JM, Shadel B, Clements B, Bronze MS. Terrorism From a Public Health Perspective. American Journal of Medical Sciences, 323:291-298, 2002.

49.Greenfield RA, Brown BR, Hutchins JB, Iandolo JJ, Jackson R, Slater LN, Bronze MD. Microbiological, Biological and Chemical Weapons of Warfare and Terrorism. American Journal of Medical Sciences, 323:326-340, 2002.

50.Greenfield RA, Drevets DA, Machado LJ, Voskuhl GW, Cornea P, Bronze MS. Bacterial Pathogens as Biological Weapons and Agents of Bioterrorism. American Journal of Medical Sciences, 323:299-315, 2002.

51.Bronze MS and Greenfield. Introduction to Bioterrorism. American Journal of Medical Sciences, 323: 289-290, 2002.

52.Greenfield RA and Bronze MS. Symposium Introduction: Clinical Aspects of Bioterrorism, J. Okla State Medical Association 9:583-586, 2003.

53.Bronze MS, Machado L, Voskuhl G, Greenfield RA. The Potential Role of Viral Pathogens as Agents of Bioterrorism. J. Okla State Med Assoc 96:29-33, 2003.

54.Bronze MS and Greenfield RA. Therapeutic Options for Diseases Due to Potential Viral Agents of Bioterrorism. Current Opinion in Investigational Drugs. 4:172-178. 2003.

55.Lutz BD, Bronze MS, and Greenfield RA. Influenza Virus: Natural Disease and Bioterrorism Threat. J Okla State Med Assoc 96: 27-28, 2003.

56.Voskuhl GW, Cornea P, Bronze MS, Greenfield RA. Other Bacterial Diseases as a Potential Consequence of Bioterrorism: Q Fever, Brucellosis, Glanders and Meloidosis. J Okla State Med Assoc 96:214-217, 2003.

57.Bronze MS and Greenfield RA. Preventive and Therapeutic Approaches to Viral Agents of Bioterrorism. Drug Discovery Today, 8:740-745, 2003.

58.Sawalha AH, Bronze MS, Saint S, Blevins S, Kern W. Step by Step. N Engl J Med 349:2253-2257, 2003.

59.Bronze MS, Huycke MM, Greenfield RA. Terrorism Symposium Update and Conclusion. J Oklahoma State Medical Association, 96:575-578, 2003.

60.Greenfield RA and Bronze MS. Prevention and Treatment of Bacterial Diseases due to Bacterial Bioterrorism Threat Agents. Drug Discovery Today, 8:881-888, 2003.

61. Gonzalez G and Bronze, MS. Proteus Infections. Emedicine. 2003.

62.Greenfield RA and Bronze MS. Current Therapy and the Development of Therapeutic Options for the Treatment of Diseases Due to Bacterial Agents of Potential Biowarfare and Bioterrorism, Current Opinion in Investigational Drugs, 5:135-140, 2004.

63.Bronze, MS and Greenfield, RA. Nipah Virus. In Fuchs, J., and Poda, M., eds. Encyclopedia of Medical Genomics and Proteomics, Marcel Dekker, New York, NY, 925-928, 2004.

64.Jackson, R and Bronze, MS. Overview and Management of Obesity in Adults. Journal of the Oklahoma State Medical Association. 97:422-426, 2004.

65.Foote, E, Postier, RG, Greenfield, RA and Bronze MS. Infectious Aortitis. Current Treatment Options in Cardiovascular Medicine, 2005, 7:89-97.

66.Sawalha, A, Saint S, Ike R, and Bronze MS. Consider The Source. New England Journal of Medicine, 2005, 353:1503-1507.

67.Smith, BJ, Lerner MR, Sy B, Lucas EA, Hanas JS, Lightfoot SA, Postier RG, Bronze, MS, and Brackett DJ. Systemic bone loss and coronary vessel disease in an animal model of chronic inflammation. Bone. 2006

Mar;38(3):378-86.

68.Gonzalez, G and Bronze, MS. Proteus Infections. Emedicine. 2005.

69.Bronze MS, Rivzi SM, and Tierney W. Overview of Hepatitis C Virus Infection. eMedicine. 2005.

70.Bronze MS and Smith B. Metabolic Bone Disease in HIV Infected Individuals (in preparation).

71.Bronze MS. Address of the President of the Southern Society for Clinical Investigation: On the Importance of Mentoring. Am J Med Sci., 2005, 330: 209-212.

72.Greenfield RA, Cooper TW, Bronze MS. Symposium on Antimicrobial Therapy: I. Principles of Antimicrobial Therapy. J. Okla State Med Assoc., 99:474-479, 2006.

73. Cooper TW, Gibbs WJ, Bronze MS, Greenfield RA. Symposium on Antimicrobial Therapy II. Introduction to Beta-Lactam Antibiotics. J Okla State Med Assoc, 99:516-520, 2006.

74. Gibbs WJ, Cooper TW, Bronze MS, Greenfield RA. Symposium on Antimicrobial Therapy. III. Penicillins. Okla State Med Assoc, 99:551-556, 2006.